Ruminations on the future of pharmacovigilance – new podcast out now

Perspective / 15 December 2022

After the pandemic: what were the lessons learnt for pharmacovigilance? Find out in the latest episode of the Drug Safety Matters podcast.


COVID-19 forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues.

Elena Rocca of Oslo Metropolitan University joins Drug Safety Matters host Federica Santoro in the studio for a philosophical inquiry into the lessons to be learnt from the pandemic – and what it can teach us about the science of drug safety.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

Risk is in the eye of the beholder when it comes to communication

You may also like

Linking Pharmacogenomics and Pharmacovigilance Data to Solve Drug-induced Problems

Pharmacovigilance has come a long way in helping us link medicines to their side-effects; with the help of pharmacogenomics it can go even further.

Perspective / 05 February 2025

How can the ‘Black Swan Theory’ help us Prevent Adverse Drug Reactions?

How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?

Perspective / 23 September 2024

Risk is in the eye of the beholder when it comes to communication

Are you and your patient talking about the same thing when you discuss risk? Most likely not, and understanding this is key to effective risk communication.

Perspective / 18 March 2024